1192159-68-4

Usage

Uses

Used in Medicinal Chemistry:
2-(2H-1,2,3-triazol-2-yl)benzoyl chloride is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its reactivity allows for the formation of various drug molecules with potential therapeutic applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(2H-1,2,3-triazol-2-yl)benzoyl chloride is used as a key building block in the synthesis of novel drug candidates. Its incorporation into molecular structures can lead to the discovery of new medications with improved efficacy and safety profiles.
Used in Organic Synthesis:
2-(2H-1,2,3-triazol-2-yl)benzoyl chloride is used as a versatile reagent in organic synthesis, enabling the creation of a wide range of chemical products. Its ability to participate in various chemical reactions makes it a valuable tool for chemists working on the development of new compounds with diverse applications.

Upstream product

• 1001401-62-2 2-(2H-1,2,3-triazol-2-yl)benzoic acid 
• 88-67-5 2-Iodobenzoic acid 

Downstream Products

• 956292-82-3 N-[2-(benzyloxy)ethyl]-N-cyclobutyl-2-(2H-1,2,3-triazol-2-yl)benzamide 

Relevant academic research and scientific papers

Octahydropyrrolo[3,4-c]pyrrole derivative and application method and application thereof

The invention relates to an octahydropyrrolo[3,4-c]pyrrole derivative and an application method and application thereof. The compound and a pharmaceutical composition containing the compound are usedfor antagonizing orexin receptors. The invention also re

Octahydropyrrolo[3,4-c]pyrrole derivatives and use thereof

The invention relates to octahydropyrrolo[3,4-c]pyrrole derivatives and a use thereof. The above compounds and a medicinal composition containing the compounds are used for suppressing an orexin receptor. The invention also relates to a method for preparing the compounds and the medicinal composition, and the use of the compounds and the medicinal composition in the treatment or prevention of orexin receptor related diseases.

Substituted aryl heteroaryl compound and application thereof

The invention relates to a substituted aryl heteroaryl compound and application thereof, and further relates to a pharmaceutical composition containing the substituted aryl heteroaryl compound and application thereof. The compound or the pharmaceutical co

OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF

The invention relates to octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof. Compounds and pharmaceutical compositions comprising the compounds provided herein are used for antagonizing orexin receptors. The invention also relates to processes for preparing the compounds and pharmaceutical compositions, and uses thereof in treating or preventing a disease related to orexin receptors.

ETHYLDIAMINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to ethyldiamne compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

Substituted heterocyclic compound, and use method and use thereof

The invention relates to a substituted heterocyclic compound, and a use method and a use thereof. The substituted heterocyclic compound and a medicinal composition including the compound can be used to depress orexin receptors, especially an orexin-1 rece

Substituted heterocyclic compound, preparation method and uses thereof

The present invention relates to a substituted heterocyclic compound, a preparation method and uses thereof, further to a pharmaceutical composition containing the heterocyclic compound and uses thereof, wherein the compound or pharmaceutical composition

PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

THIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to thiazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thiazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

OXAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.